missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ JTE 607 Dihydrochloride
Description
JTE 607 dihydrochloride is a pro-drug that is cleaved by carboxylesterase 1 (CES1) to its active metabolite, which then binds to cleavage and polyadenylation specificity factor 3 (CPSF3; Kd = 370 nM at human CPSF3). Treatment of A-673 cells with JTE 607 results in inhibition of mRNA cleavage and accumulation of nuclear R-loops. JTE 607 induces apoptosis in leukemia cells in vitro and prolongs survival in a mouse leukemia model. JTE 607 inhibits cytokine release and inhibits production of IL-1β, IL-8, IL-6, IL-10 and TNFα (IC50 values are 5.9, 7.3, 8.8, 9.1 and 11.0 nM, respectively) from LPS-stimulated PBMCs. In a rat model of lung injury, JTE 607 reduces proinflammatory cytokine-release and attenuates lung permeability.
Specifications
Specifications
| Chemical Name or Material | JTE 607 dihydrochloride |
| CAS | 188791-09-5 |
| Synonym | N-[3,5-Dichloro-2-hydroxy-4-[2-(4-methyl-1-piperazinyl)ethoxy]benzoyl]-L-phenylalanine ethyl ester dihydrochloride |
| Quantity | 50 mg |
| Solubility | Soluble to 100mM in water and to 100mM in DMSO |
| Product Line | Tocris |
| Molecular Formula | C25H31Cl2N3O5·2HCl |
| Formula Weight | 597.36 |
| Physical Form | Solid |
| Product Type | Bioactive Small Molecule |
| Show More |
Research Use Only. Not For Human or Veterinary Use